We are live on ! Find out more
TWA

TCI Wealth Advisors Portfolio holdings

AUM $2.31B
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-13.2%
1 Year Est. Return
+26.52%
3 Year Est. Return
+65.05%
5 Year Est. Return
+75.05%
10 Year Est. Return
+319.89%
AUM
$654M
AUM Growth
-$13.8M
Cap. Flow
+$90.3M
Cap. Flow %
13.81%
Top 10 Hldgs %
61.86%
Holding
2,649
New
341
Increased
678
Reduced
602
Closed
269

Sector Composition

Rank Sector Weight
1 Technology 5.39%
2 Healthcare 4.35%
3 Industrials 3.04%
4 Consumer Discretionary 2.88%
5 Financials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIDE
2601
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
-115
Closed -$6K
SEAC
2602
DELISTED
Seachange International Inc
SEAC
-30
Closed -$1K
CSII
2603
DELISTED
Cardiovascular Systems, Inc.
CSII
-295
Closed -$7K
OIG
2604
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$0 ﹤0.01%
8
RAMMW
2605
DELISTED
Aries I Acquisition Corporation
RAMMW
$0 ﹤0.01%
9
RAM
2606
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
$0 ﹤0.01%
18
SIOX
2607
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$0 ﹤0.01%
700
LYLT
2608
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-4
Closed
SFT
2609
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-219
Closed -$5K
ALBO
2610
DELISTED
Albireo Pharma Inc
ALBO
-189
Closed -$6K
WEBR
2611
DELISTED
Weber Inc.
WEBR
-366
Closed -$4K
CTAQU
2612
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$0 ﹤0.01%
45
VLDR
2613
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$0 ﹤0.01%
42
-1,150
-96% -$1.99K
CPARW
2614
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$0 ﹤0.01%
3
CPAR
2615
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$0 ﹤0.01%
15
PRBM
2616
DELISTED
Parabellum Acquisition Corp.
PRBM
$0 ﹤0.01%
28
CIXX
2617
DELISTED
CI Financial Corp.
CIXX
$0 ﹤0.01%
30
EAR
2618
DELISTED
Eargo, Inc. Common Stock
EAR
-52
Closed -$6K
OYST
2619
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$0 ﹤0.01%
50
CLVS
2620
DELISTED
Clovis Oncology, Inc.
CLVS
-2,340
Closed -$5K
HTGM
2621
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$0 ﹤0.01%
2
ECOM
2622
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-235
Closed -$4K
PRBM.WS
2623
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$0 ﹤0.01%
21
PZN
2624
DELISTED
Pzena Investment Management, Inc. Class A
PZN
-462
Closed -$4K
ATHX
2625
DELISTED
Athersys, Inc. Common Stock
ATHX
$0 ﹤0.01%
40
-40
-50% -$443

Similar funds

TCI Wealth Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, TCI Wealth Advisors held 2,649 positions worth $654M, down 2.1% from $667M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

TCI Wealth Advisors deployed $90.3M of net new capital in Q2 2022, opening 341 new positions and adding to 678 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 1,881,030 shares worth $59.4M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $3.32M trimmed.

  • TCI Wealth Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 1,881,030 shares worth $59.4M.
  • TCI Wealth Advisors added most to iShares Core US Aggregate Bond ETF in Q2 2022, an estimated $9.51M increase.
  • TCI Wealth Advisors's biggest Q2 2022 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $3.32M.
  • TCI Wealth Advisors fully exited Avantis US Large Cap Value ETF in Q2 2022, selling an estimated $65K.
  • TCI Wealth Advisors's ten largest holdings make up 62% of its $654M portfolio in Q2 2022.
  • TCI Wealth Advisors opened 341 new positions and closed 269 in Q2 2022.
  • TCI Wealth Advisors's portfolio value fell 2.1% quarter-over-quarter to $654M.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.